Ultra-early endoscopy for non-variceal upper GI bleeding did not reduce death or rebleeding

Design

Systematic review and meta-analysis

Population

9 studies, 10,785 adults with non-variceal upper GI bleeding

Primary outcome

Mortality and rebleeding

Effect

Mortality OR 0.88 (0.58 to 1.34); rebleeding OR 1.23 (0.90 to 1.67); ICU admission OR 1.41

A meta-analysis pooled nine studies, 10,785 adults with non-variceal upper gastrointestinal bleeding, comparing endoscopy within six hours with later endoscopy, usually within 24 hours.

Ultra-early endoscopy did not reduce mortality (OR 0.88, 95% CI 0.58 to 1.34) or rebleeding (OR 1.23, 0.90 to 1.67), and made no difference to transfusion, surgery, repeat endoscopy or length of stay. ICU admission was more frequent (OR 1.41, 1.20 to 1.66), perhaps because sicker patients were scoped sooner or because rushed procedures needed closer monitoring. Results were similar in high-risk patients, most often defined by a Glasgow-Blatchford score above 12.

This supports current guidance to resuscitate first and perform endoscopy within 24 hours, rather than racing to scope in the first hours. It does not apply to variceal bleeding or to patients who remain unstable despite resuscitation.

The included studies varied in design and in how they timed endoscopy, so the comparison may be confounded by who was scoped early.

• Resuscitate first: restore circulation, transfuse to a restrictive target and correct coagulopathy
• Aim for endoscopy within 24 hours in non-variceal upper GI bleeding
• Do not rush to scope within six hours in a patient who is stabilising
• Escalate urgently for patients who stay unstable despite resuscitation
• Start a proton pump inhibitor and manage suspected variceal bleeding on its own pathway

Why it matters

It reduces pressure for night-time endoscopy in patients who are responding to resuscitation.

Don't overread it

The results do not apply to unstable or variceal bleeding, and timing was not randomised in every study.

The statistics, in plain English

The mortality odds ratio of 0.88 has an interval from 0.58 to 1.34, so the data allow a modest benefit or harm and show no clear effect. Where timing was not randomised, early-scoped patients may have differed in severity.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.